Receptors, Glucagon, antagonists & inhibitors
- Name
- Receptors, Glucagon, antagonists & inhibitors
- Accession Number
- DBCAT003205
- Description
Not Available
- Drugs
Drug Drug Description MK-0893 MK0893 has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Diabetes Mellitus, Type 2. Volagidemab Volagidemab is under investigation in clinical trial NCT03117998 (Multiple Dose Study to Evaluate the Efficacy, Safety and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus). - Drugs & Drug Targets
Drug Target Type